Resource ValueSet/FHIR Server from package hl7.fhir.us.pq-cmc-fda#current (47 ms)

Resources that use this resource

StructureDefinition
pqcmc-batch-formula-product	Batch Formula Drug Product Identification
pqcmc-drug-product-description	Drug Product Description
pqcmc-drug-product-handle	Drug Product Handle
pqcmc-drug-product-with-impurities	Drug Product Impurities

Resources that this resource uses

CodeSystem
http://terminology.hl7.org/CodeSystem/v3-EntityNamePartQualifierR2	EntityNamePartQualifierR2

Narrative

Note: links and images are rebased to the (stated) source

Source

{
  "resourceType" : "ValueSet",
  "id" : "pqcmc-name-part-terminology",
  "text" : {
    "status" : "extensions",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ValueSet pqcmc-name-part-terminology</b></p><a name=\"pqcmc-name-part-terminology\"> </a><a name=\"hcpqcmc-name-part-terminology\"> </a><a name=\"pqcmc-name-part-terminology-en-US\"> </a><ul><li>Include these codes as defined in <a href=\"http://terminology.hl7.org/6.1.0/CodeSystem-v3-EntityNamePartQualifierR2.html\"><code>http://terminology.hl7.org/CodeSystem/v3-EntityNamePartQualifierR2</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a href=\"http://terminology.hl7.org/6.1.0/CodeSystem-v3-EntityNamePartQualifierR2.html#v3-EntityNamePartQualifierR2-CON\">CON</a></td><td>container name</td><td>**Description:** This refers to the container if present in the medicinal product name.<br/><br/>EXAMPLES:<br/><br/> *  For Optaflu suspension for injection in pre-filled syringe Influenza vaccine (surface antigen, inactivated, prepared in cell culture) (2007/2008 season): pre-filled syringe</td></tr><tr><td><a href=\"http://terminology.hl7.org/6.1.0/CodeSystem-v3-EntityNamePartQualifierR2.html#v3-EntityNamePartQualifierR2-DEV\">DEV</a></td><td>device name</td><td>**Description:** This refers to the qualifiers in the name for devices and is at the moment mainly applicable to insulins and inhalation products.<br/><br/>EXAMPLES:<br/><br/> *  For the medicinal product Actrapid FlexPen 100 IU/ml Solution for injection Subcutaneous use: FlexPen.</td></tr><tr><td><a href=\"http://terminology.hl7.org/6.1.0/CodeSystem-v3-EntityNamePartQualifierR2.html#v3-EntityNamePartQualifierR2-FLAV\">FLAV</a></td><td>FlavorName</td><td>**Description:** This refers to a flavor of the medicinal product if present in the medicinal product name.<br/><br/>**Examples:**<br/><br/> *  For 'CoughCure Linctus Orange Flavor', the flavor part is &quot;Orange&quot;<br/> *  For 'Wonderdrug Syrup Cherry Flavor', the flavor part is &quot;Cherry&quot;</td></tr><tr><td><a href=\"http://terminology.hl7.org/6.1.0/CodeSystem-v3-EntityNamePartQualifierR2.html#v3-EntityNamePartQualifierR2-FORMUL\">FORMUL</a></td><td>FormulationPartName</td><td>**Description:** This refers to the formulation of the medicinal product if present in the medicinal product name.<br/><br/>**Examples:**<br/><br/> *  For 'SpecialMed Sugar Free Cough Syrup', the formulation name part is &quot;Sugar Free&quot;<br/> *  For 'QuickCure Gluten-free Bulk Fibre', the formulation name part is &quot;gluten-free&quot;</td></tr><tr><td><a href=\"http://terminology.hl7.org/6.1.0/CodeSystem-v3-EntityNamePartQualifierR2.html#v3-EntityNamePartQualifierR2-FRM\">FRM</a></td><td>form name</td><td>**Description:** This refers to the pharmaceutical form/ if present in the medicinal product name.<br/><br/>EXAMPLES:<br/><br/> *  For Agenerase 50 mg soft capsules: Soft Capsules<br/> *  For Ludiomil 25mg-Filmtabletten: Filmtabletten<br/> *  For Optaflu suspension for injection in pre-filled syringe Influenza vaccine (surface antigen, inactivated, prepared in cell culture) (2007/2008 season): suspension for injection</td></tr><tr><td><a href=\"http://terminology.hl7.org/6.1.0/CodeSystem-v3-EntityNamePartQualifierR2.html#v3-EntityNamePartQualifierR2-INV\">INV</a></td><td>invented name</td><td>**Description:** This refers to the product name without the trademark or the name of the marketing authorization holder or any other descriptor reflected in the product name and, if appropriate, whether it is intended e.g. for babies, children or adults.<br/><br/>EXAMPLES:<br/><br/> *  Agenerase<br/> *  Optaflu<br/> *  Ludiomil</td></tr><tr><td><a href=\"http://terminology.hl7.org/6.1.0/CodeSystem-v3-EntityNamePartQualifierR2.html#v3-EntityNamePartQualifierR2-POPUL\">POPUL</a></td><td>TargetPopulationName</td><td>**Description:** This refers to the target population for the medicinal product if present in the medicinal product name<br/><br/>**Examples:**<br/><br/> *  For 'Broncho-Drug 3.5 mg-capsules for children', the target population part is &quot;children&quot;<br/> *  For 'Adult Chesty Cough Syrup', the target population part is &quot;adult&quot;</td></tr><tr><td><a href=\"http://terminology.hl7.org/6.1.0/CodeSystem-v3-EntityNamePartQualifierR2.html#v3-EntityNamePartQualifierR2-SCI\">SCI</a></td><td>scientific name</td><td>**Description:** This refers to the product common or scientific name without the trademark or the name of the marketing authorization holder or any other descriptor reflected in the product name.<br/><br/>EXAMPLES:<br/><br/> *  For Agenerase: N/A<br/> *  For Optaflu: Influenza vaccine (surface antigen, inactivated, prepared in cell culture) (2007/2008 season)<br/> *  For Ludiomil: N/A</td></tr><tr><td><a href=\"http://terminology.hl7.org/6.1.0/CodeSystem-v3-EntityNamePartQualifierR2.html#v3-EntityNamePartQualifierR2-STR\">STR</a></td><td>strength name</td><td>**Description:** This refers to the strength if present in the medicinal product name. The use of decimal points should be accommodated if required.<br/><br/>EXAMPLES:<br/><br/> *  For Agenerase 50 mg soft capsules: 50mg<br/> *  For Ludiomil 25mg-Filmtabletten: 25 mg<br/> *  For Optaflu suspension for injection in pre-filled syringe Influenza vaccine (surface antigen, inactivated, prepared in cell culture) (2007/2008 season): N/A</td></tr><tr><td><a href=\"http://terminology.hl7.org/6.1.0/CodeSystem-v3-EntityNamePartQualifierR2.html#v3-EntityNamePartQualifierR2-TIME\">TIME</a></td><td>TimeOrPeriodName</td><td>**Description:** This refers to a time or time period that may be specified in the text of the medicinal product name<br/><br/>**Example:**<br/><br/> *  For an influenza vaccine 'Drug-FLU season 2008/2009', the time/period part is &quot;2008/2009 season&quot;</td></tr><tr><td><a href=\"http://terminology.hl7.org/6.1.0/CodeSystem-v3-EntityNamePartQualifierR2.html#v3-EntityNamePartQualifierR2-TMK\">TMK</a></td><td>trademark name</td><td>**Description:** This refers to trademark/company element if present in the medicinal product name.<br/><br/>EXAMPLES:<br/><br/> *  for Insulin Human Winthrop Comb 15: Winthrop</td></tr><tr><td><a href=\"http://terminology.hl7.org/6.1.0/CodeSystem-v3-EntityNamePartQualifierR2.html#v3-EntityNamePartQualifierR2-USE\">USE</a></td><td>intended use name</td><td>**Description:** This refers to the intended use if present in the medicinal product name without the trademark or the name of the marketing authorization holder or any other descriptor reflected in the product name.<br/><br/>**Examples:**<br/><br/> *  For 'Drug-BI Caplets - Heartburn Relief', the intended use part is: &quot;Heartburn Relief&quot;<br/> *  For 'Medicine Honey Syrup for Soothing Coughs' the intended use part is &quot;Soothing Coughs&quot;</td></tr></table></li></ul></div>"
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
      "valueCode" : "brr"
    }
  ],
  "url" : "http://hl7.org/fhir/us/pq-cmc-fda/ValueSet/pqcmc-name-part-terminology",
  "identifier" : [
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.113883.4.642.40.36.48.14"
    }
  ],
  "version" : "2.0.0-ballot",
  "name" : "PqcmcNamePartTerminology",
  "title" : "PQCMC Name Part Terminology",
  "status" : "active",
  "experimental" : false,
  "date" : "2024-12-12T01:58:44+00:00",
  "publisher" : "HL7 International / Biomedical Research and Regulation",
  "contact" : [
    {
      "name" : "HL7 International / Biomedical Research and Regulation",
      "telecom" : [
        {
          "system" : "url",
          "value" : "http://www.hl7.org/Special/committees/rcrim"
        },
        {
          "system" : "email",
          "value" : "brr@lists.HL7.org"
        }
      ]
    }
  ],
  "description" : "Terminology used to qualify the information pertaining to Name Part data in the framework of the Pharmaceutical Quality/Chemistry, Manufacturing and Controls documents.",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "US",
          "display" : "United States of America"
        }
      ]
    }
  ],
  "compose" : {
    "include" : [
      {
        "system" : "http://terminology.hl7.org/CodeSystem/v3-EntityNamePartQualifierR2",
        "concept" : [
          {
            "code" : "CON",
            "display" : "container name"
          },
          {
            "code" : "DEV",
            "display" : "device name"
          },
          {
            "code" : "FLAV",
            "display" : "FlavorName"
          },
          {
            "code" : "FORMUL",
            "display" : "FormulationPartName"
          },
          {
            "code" : "FRM",
            "display" : "form name"
          },
          {
            "code" : "INV",
            "display" : "invented name"
          },
          {
            "code" : "POPUL",
            "display" : "TargetPopulationName"
          },
          {
            "code" : "SCI",
            "display" : "scientific name"
          },
          {
            "code" : "STR",
            "display" : "strength name"
          },
          {
            "code" : "TIME",
            "display" : "TimeOrPeriodName"
          },
          {
            "code" : "TMK",
            "display" : "trademark name"
          },
          {
            "code" : "USE",
            "display" : "intended use name"
          }
        ]
      }
    ]
  }
}

XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.